LAUREN RIDGWAY: Open Payments
NPI 1497990725 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 36 payments from 15 companies in 2025. Trend: 2023 $480 · 2024 $1,348 · 2025 $860
Food & beverage: $762Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $188 |
| Novartis Pharmaceuticals Corporation | 4 | $153 |
| Janssen Biotech, Inc. | 6 | $133 |
| ABBVIE INC. | 4 | $81 |
| Lilly USA, LLC | 3 | $57 |
| MIMEDX Group, Inc. | 2 | $45 |
| Amgen Inc. | 2 | $41 |
| Galderma Laboratories, L.P. | 2 | $30 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $29 |
| GENZYME CORPORATION | 1 | $25 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, TALTZ, Rhapsido, OTEZLA, NEMLUVIO, Leqselvi.
Industry payments across KY — which companies pay providers there.
